Board Member
Board member since
2022
Nationality
Swedish
Born
1961
Independent
Board committees, LEO Pharma
Member of the Innovation Committee and the Remuneration and Nomination Committee.
Positions and management duties
Managing director of EJM Consulting Sàrl and partner of Ventac Partners. Chair of EPICS Therapeutics SA.
Career
Former Chief Medical Officer at Kuste Biopharma and Chief Development Officer at Ixaltis SA. Previous executive roles at Janssen Pharmaceuticals (J&J), Bristol-Myers Squibb and Serono International. Previously a board member of Egetis Therapeutics AB, Amolyt Pharma SA, Swedish Orphan Biovitrum AB and Lakefront Biotherapeutics NV (formerly Galapagos NV) (RemCo Chair)
Special competencies
Extensive executive and board experience in global pharmaceuticals and biotech as well as extensive experience of interacting with health authorities (U.S. and EU). Led clinical development programs, late-stage product launches and medical affairs projects at Janssen, Bristol-Myers Squibb and Serono. Advanced business development, portfolio strategy and clinical development at Ixaltis, Kuste Biopharma and in current board roles
Meet our Board of Directors
The Board of Directors is accountable for LEO Pharma’s corporate governance, strategic direction, and long-term sustainability.
